Imperial College London
Clinical trials sponsored by Imperial College London, explained in plain language.
-
Radioactive drug tested to stop Cancer's return after liver surgery
Disease control TerminatedThis study tested whether giving Lutathera, a targeted radioactive drug, after surgery to remove neuroendocrine tumor spread in the liver could prevent the cancer from coming back. It compared this treatment against standard monitoring and supportive care in patients whose primar…
Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Study tests if diabetes tech can 'Talk' to different pumps
Disease control TerminatedThis small, terminated study aimed to see if a proven diabetes control algorithm could work with a different brand of insulin pump. It tested this automated system in one adult with type 1 diabetes to check if it was feasible and to gather early data on blood sugar control. The g…
Phase: NA • Sponsor: Imperial College London • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Tiny trial tests custom radiation doses for tough liver tumors
Disease control TerminatedThis study tested a personalized radiation treatment for adults with liver cancer that could not be removed by surgery. Doctors first gave a tiny 'scout' dose to see where it went, then calculated a custom therapeutic dose for each patient. The main goals were to check the treatm…
Phase: NA • Sponsor: Imperial College London • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
AI heart test could cut failed surgeries in half
Knowledge-focused TerminatedThis study aims to help doctors predict which patients with a persistent, irregular heart rhythm (atrial fibrillation) will benefit most from a corrective procedure called ablation. Currently, about half of patients don't get lasting improvement from this surgery. Researchers wil…
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:08 UTC